source
- FDA advisory panel backs Grail's Galleri multi-cancer blood test, citing benefits outweigh risksThe Food and Drug Administration’s advisory committee voted to endorse Galleri, a blood test from Grail that screens for multiple cancers, saying the benefits outweigh the risks. The panel’s vote…
- Flagship Pioneering secures Pentagon contract to develop biological threat countermeasuresFlagship Pioneering, a biotech investment firm, has been awarded a contract by the U.S. Department of Defense. The contract aims to advance technologies that can serve as countermeasures against b…